VG
venBio Global Strategic Fund IV, L.P. bought $6.5M of ATTO stock
venBio Global Strategic Fund IV, L.P., 10% owner of Attovia Therapeutics, Inc. (ATTO), bought 382,352 shares of ATTO stock worth $6.5M, per an SEC Form 4 filed Aug 10, 2026.
It was an open-market purchase.
The trade happened on Aug 6, 2026, 4 days before it was made public.
ATTO has moved -25.8% since the trade date, from $20.38 to $15.13 (Nov 13, 2026 close).
- Traded
- Aug 6, 2026
- Disclosed
- Aug 10, 2026
- Filing delay
- 4 days
- Price since
- -25.8%
- Role
- 10% owner
- Source
- SEC Form 4